• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威布尔模型在高脂血症患者甘油三酯管理中应用于他汀类药物的研究

Application of the Weibull Model to Statins for Triglyceride Management in Patients With Hyperlipidaemia.

作者信息

Nakayama Natsuki, Imai Kuniharu, Niwa Shiori, Moriwaki Yoshimi, Oshima Chika, Furukawa Nozomi, Hirai Makoto

机构信息

Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Nursing Sciences, Fukui Prefectural University, Fukui, Japan.

出版信息

Pharmacol Res Perspect. 2025 Aug;13(4):e70159. doi: 10.1002/prp2.70159.

DOI:10.1002/prp2.70159
PMID:40762405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12322927/
Abstract

Dyslipidemia, characterized by abnormal serum cholesterol or triglyceride (TG) concentrations, is prevalent among middle-aged and older adults and contributes to atherosclerosis and increased cardiovascular risk. Although oral statins effectively decrease low-density lipoprotein cholesterol, patients with high-TG concentrations remain at significant risk for atherosclerotic cardiovascular disease. Weibull analysis, a statistical method widely applied in reliability engineering and medicine, is suitable for assessing arterial stiffness, which reflects vascular aging or deterioration. This study explored the relationship between TG concentrations and arterial stiffness via Weibull analysis in patients treated with statins (STG) and patients without statin treatment (No-STG). The mode of the Weibull distribution was greater for STG (97.8 mg/dL) than for No-STG (80.7 mg/dL). Notably, compared with No-STG patients, STG patients presented lower hazard functions for TG concentrations up to 170 mg/dL. However, above 170 mg/dL, the hazard function for STG was equal to or slightly greater than that for No-STG. These findings suggest that without statin therapy, atherosclerosis may develop at lower TG concentrations, whereas statins effectively delay its onset. However, the data also highlight the limitations of statins in significantly reducing TG concentrations. This information underscores the importance of patient education in preventing the progression of atherosclerosis. Encouraging lifestyle changes, including improved exercise and dietary habits, can complement statin therapy to optimize cardiovascular health. These findings provide a basis for promoting patient awareness and fostering the proactive management of cardiovascular risk factors.

摘要

血脂异常以血清胆固醇或甘油三酯(TG)浓度异常为特征,在中老年人中普遍存在,并会导致动脉粥样硬化和心血管风险增加。尽管口服他汀类药物能有效降低低密度脂蛋白胆固醇,但TG浓度高的患者仍有患动脉粥样硬化性心血管疾病的重大风险。威布尔分析是一种广泛应用于可靠性工程和医学的统计方法,适用于评估反映血管老化或恶化的动脉僵硬度。本研究通过威布尔分析探讨了他汀类药物治疗患者(STG)和未接受他汀类药物治疗患者(No-STG)中TG浓度与动脉僵硬度之间的关系。STG的威布尔分布众数(97.8mg/dL)高于No-STG(80.7mg/dL)。值得注意的是,与No-STG患者相比,STG患者在TG浓度高达170mg/dL时呈现出较低的风险函数。然而,在170mg/dL以上,STG的风险函数等于或略高于No-STG。这些发现表明,在没有他汀类药物治疗的情况下,较低的TG浓度可能会引发动脉粥样硬化,而他汀类药物能有效延迟其发病。然而,数据也凸显了他汀类药物在显著降低TG浓度方面的局限性。这些信息强调了患者教育在预防动脉粥样硬化进展中的重要性。鼓励改变生活方式,包括加强锻炼和改善饮食习惯,可以补充他汀类药物治疗,以优化心血管健康。这些发现为提高患者意识和积极管理心血管危险因素提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/9ff4cf49f201/PRP2-13-e70159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/c2ab076ba1a1/PRP2-13-e70159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/8e644bb7baa5/PRP2-13-e70159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/9ff4cf49f201/PRP2-13-e70159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/c2ab076ba1a1/PRP2-13-e70159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/8e644bb7baa5/PRP2-13-e70159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e9/12322927/9ff4cf49f201/PRP2-13-e70159-g001.jpg

相似文献

1
Application of the Weibull Model to Statins for Triglyceride Management in Patients With Hyperlipidaemia.威布尔模型在高脂血症患者甘油三酯管理中应用于他汀类药物的研究
Pharmacol Res Perspect. 2025 Aug;13(4):e70159. doi: 10.1002/prp2.70159.
2
Lipid-lowering agents for nephrotic syndrome.用于肾病综合征的降脂药物。
Cochrane Database Syst Rev. 2013 Dec 10;2013(12):CD005425. doi: 10.1002/14651858.CD005425.pub2.
3
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.肾移植受者使用的HMG CoA还原酶抑制剂(他汀类药物)
Cochrane Database Syst Rev. 2014 Jan 28;2014(1):CD005019. doi: 10.1002/14651858.CD005019.pub4.
4
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.PCSK9 抑制剂和依折麦布降低心血管事件风险的临床实践指南:基于风险分层的推荐意见。
BMJ. 2022 May 4;377:e069066. doi: 10.1136/bmj-2021-069066.
5
Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.时间疗法与传统他汀类药物疗法治疗高脂血症的比较。
Cochrane Database Syst Rev. 2016 Nov 26;11(11):CD009462. doi: 10.1002/14651858.CD009462.pub2.
6
HMG CoA reductase inhibitors (statins) for dialysis patients.用于透析患者的HMG CoA还原酶抑制剂(他汀类药物)。
Cochrane Database Syst Rev. 2013 Sep 11;2013(9):CD004289. doi: 10.1002/14651858.CD004289.pub5.
7
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.围手术期他汀类药物治疗以改善非心脏血管手术期间及术后的结局。
Cochrane Database Syst Rev. 2013 Jul 3;2013(7):CD009971. doi: 10.1002/14651858.CD009971.pub2.
8
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
9
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Weibull Regression and Machine Learning Survival Models: Methodology, Comparison, and Application to Biomedical Data Related to Cardiac Surgery.威布尔回归与机器学习生存模型:方法、比较及在心脏外科生物医学数据中的应用
Biology (Basel). 2023 Mar 13;12(3):442. doi: 10.3390/biology12030442.
2
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.急性冠脉综合征后 LDL-C 降低:早治疗,强治疗:从证据到临床实践。急性心血管护理协会(ACVC)联合欧洲预防心脏病学协会(EAPC)和欧洲心脏病学会心血管药物治疗工作组共同制定的临床共识声明。
Eur Heart J Acute Cardiovasc Care. 2022 Dec 27;11(12):939-949. doi: 10.1093/ehjacc/zuac123.
3
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health.关于 ω-3 多不饱和脂肪酸对心血管健康影响的最新研究进展。
Nutrients. 2022 Dec 3;14(23):5146. doi: 10.3390/nu14235146.
4
Hypertriglyceridemia.高甘油三酯血症。
Endocrinol Metab Clin North Am. 2022 Sep;51(3):539-555. doi: 10.1016/j.ecl.2022.02.010. Epub 2022 Jul 4.
5
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017-2020.在美国动脉粥样硬化性血管疾病一级和二级预防中他汀类药物使用的负担和预测因素:来自 2017-2020 年全国健康和营养调查。
Eur J Prev Cardiol. 2022 Oct 20;29(14):1830-1838. doi: 10.1093/eurjpc/zwac103.
6
Vascular Stiffness in Aging and Disease.衰老与疾病中的血管僵硬度
Front Physiol. 2021 Dec 7;12:762437. doi: 10.3389/fphys.2021.762437. eCollection 2021.
7
A parsimonious model to validate cost-effectiveness analyses on preventive health care.一个用于验证预防性保健成本效益分析的简约模型。
BMC Health Serv Res. 2021 Nov 9;21(1):1213. doi: 10.1186/s12913-021-07217-2.
8
A Modern Approach to Dyslipidemia.血脂异常的现代治疗方法
Endocr Rev. 2022 Jul 13;43(4):611-653. doi: 10.1210/endrev/bnab037.
9
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.心血管疾病与胰腺炎防治中的高甘油三酯血症的临床管理。
Curr Atheroscler Rep. 2021 Sep 13;23(11):72. doi: 10.1007/s11883-021-00962-z.
10
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.2021年美国心脏病学会(ACC)关于持续性高甘油三酯血症患者降低动脉粥样硬化性心血管疾病(ASCVD)风险管理的专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2021 Aug 31;78(9):960-993. doi: 10.1016/j.jacc.2021.06.011. Epub 2021 Jul 28.